ROIV
Price
$34.96
Change
+$0.91 (+2.67%)
Updated
Jul 21 closing price
Capitalization
24.49B
27 days until earnings call
Intraday BUY SELL Signals
VERA
Price
$37.16
Change
+$0.17 (+0.46%)
Updated
Jul 21, 04:59 PM (EDT)
Capitalization
2.66B
16 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ROIV vs VERA

ROIV vs VERA Comparison Chart in %
View a ticker or compare two or three
VS
ROIV vs. VERA commentary
Jul 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ROIV is a StrongBuy and VERA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2026
Stock price -- (ROIV: $34.05 vs. VERA: $36.99)
Brand notoriety: ROIV and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ROIV: 46% vs. VERA: 42%
Market capitalization -- ROIV: $24.49B vs. VERA: $2.66B
ROIV [@Biotechnology] is valued at $24.49B. VERA’s [@Biotechnology] market capitalization is $2.66B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.95B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ROIV’s FA Score shows that 1 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • ROIV’s FA Score: 1 green, 4 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, both ROIV and VERA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ROIV’s TA Score shows that 4 TA indicator(s) are bullish while VERA’s TA Score has 5 bullish TA indicator(s).

  • ROIV’s TA Score: 4 bullish, 5 bearish.
  • VERA’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, both ROIV and VERA are a bad buy in the short-term.

Price Growth

ROIV (@Biotechnology) experienced а -1.33% price change this week, while VERA (@Biotechnology) price change was -10.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.38%. For the same industry, the average monthly price growth was +2.73%, and the average quarterly price growth was +1869.71%.

Reported Earning Dates

ROIV is expected to report earnings on Aug 17, 2026.

VERA is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (-2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($24.5B) has a higher market cap than VERA($2.66B). ROIV YTD gains are higher at: 56.912 vs. VERA (-26.955). VERA has higher annual earnings (EBITDA): -360.87M vs. ROIV (-1.28B). ROIV has more cash in the bank: 4.29B vs. VERA (597M). VERA has less debt than ROIV: VERA (76.9M) vs ROIV (107M). ROIV has higher revenues than VERA: ROIV (8.26M) vs VERA (0).
ROIVVERAROIV / VERA
Capitalization24.5B2.66B923%
EBITDA-1.28B-360.87M355%
Gain YTD56.912-26.955-211%
P/E Ratio1.97N/A-
Revenue8.26M0-
Total Cash4.29B597M719%
Total Debt107M76.9M139%
TECHNICAL ANALYSIS
Technical Analysis
ROIVVERA
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 26 days ago
77%
Bullish Trend 26 days ago
85%
Declines
ODDS (%)
Bearish Trend 6 days ago
71%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ROIV
Daily Signal:
Gain/Loss:
VERA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IBGK22.84N/A
N/A
iShares iBonds Dec 2054 Term Trsy ETF
QMMY25.89-0.01
-0.05%
FT Vest Nasdaq-100 Mod Buffr ETF - May
HAWX44.51-0.11
-0.25%
iShares Currency Hdgd MSCI ACWI exUS ETF
FNCL79.99-0.33
-0.41%
Fidelity MSCI Financials ETF
INDL43.54-0.65
-1.47%
Direxion Daily MSCI India Bull 2x ETF

VERA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERA has been loosely correlated with CLDX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if VERA jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERA
1D Price
Change %
VERA100%
-3.92%
CLDX - VERA
43%
Loosely correlated
+0.20%
PCVX - VERA
43%
Loosely correlated
-1.25%
COGT - VERA
41%
Loosely correlated
-2.00%
KURA - VERA
40%
Loosely correlated
-1.66%
ROIV - VERA
39%
Loosely correlated
-1.33%
More